Walleye Trading
BIVV

Walleye Trading’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Walleye Trading’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-450
Closed -$24 – 5016
2017
Q4 		$24 Hold
450
– – ﹤0.01% 4152
2017
Q3 		$26 Sell
450
-450
-50% -$26.4K ﹤0.01% 3893
2017
Q2 		$54 Sell
900
-400
-31% -$22.8K ﹤0.01% 3861
2017
Q1 		$71 Buy
+1,300
New +$64K ﹤0.01% 3611

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Walleye Trading's BIVV Position: Q1 2018 in Review

Walleye Trading sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,010 shares — an estimated $54 sold.

Walleye Trading first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.33K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Walleye Trading reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Walleye Trading sold 1,010 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $54.
  • Walleye Trading first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Walleye Trading's Bioverativ Inc. Common Stock position peaked at $1.33K in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Walleye Trading's 13F filing for Q1 2018, filed 15 May 2018.